Health Journal Online

Tag: Artery

  • Genicular Artery Embolization Delivered 12 Months of Knee Arthritis Pain Relief without Surgery in Nearly 200 Patients

    Genicular Artery Embolization Delivered 12 Months of Knee Arthritis Pain Relief without Surgery in Nearly 200 Patients

    For millions of people living with knee osteoarthritis, the current treatment ladder has a frustrating middle step that is largely empty. Conservative measures — physical therapy, NSAIDs, corticosteroid injections — provide relief that wanes over months. Full joint replacement surgery is effective but invasive, carries surgical risks, requires weeks of rehabilitation, and comes with a prosthetic lifespan of 15 to 20 years, making it poorly suited for younger or less medically robust patients who face decades of living with arthritis.

    Between those two rungs is a gap that has driven years of research into minimally invasive interventional options. A study published June 16, 2026, in Radiology — the flagship journal of the Radiological Society of North America — now provides the strongest evidence yet that one of those options delivers a full year of meaningful pain relief and functional improvement for appropriately selected patients.

    “For many patients with knee osteoarthritis, there is a real treatment gap today,” said lead author Florian Nima Fleckenstein, M.D., deputy head of Interventional Radiology Campus Mitte at Charité — Universitätsmedizin Berlin. “Conservative measures such as intra-articular injections no longer provide sufficient relief, but joint replacement is not an option for medical or personal reasons.”

    What Genicular Artery Embolization Is — and How It Works

    Genicular artery embolization (GAE) is a minimally invasive procedure performed by interventional radiologists using fluoroscopy (real-time X-ray imaging) and catheter-based techniques. The procedure targets a specific feature of the arthritic knee joint that conventional treatments have largely ignored: abnormal blood vessel formation.

    According to ScienceDaily’s coverage, in a healthy knee, the synovial tissue and supporting structures maintain a normal, controlled blood supply. In osteoarthritis, the chronic inflammation process triggers the growth of abnormal new blood vessels — called neovascularization — in and around the joint. These pathological vessels contribute to sustained inflammation and pain. Standard treatments target the inflammation downstream; GAE targets the vascular supply driving it.

    During GAE, an interventional radiologist threads a thin catheter through a puncture in the femoral artery, navigates it to the genicular arteries supplying the knee, and injects tiny microspheres that block blood flow to the abnormal vessels. By shutting down these pathological vessels, the procedure aims to reduce the vascular contribution to joint inflammation — producing pain relief and functional improvement without cutting, implanting, or removing anything.

    The version studied in the June 2026 Radiology paper uses rapidly resorbable, gelatin-based microspheres — a key distinction from earlier GAE studies that used permanent microspheres. The resorbable particles dissolve in the body over time, potentially reducing risks associated with permanent vascular occlusion in the lower extremity.

    GAE Radiology Study Key Data (June 16, 2026) Detail
    Published in Radiology (RSNA), June 16, 2026
    DOI 10.1148/radiol.253312
    Lead author Florian Nima Fleckenstein, M.D., Charité – Universitätsmedizin Berlin
    Total patients included 333
    Patients analyzed at 12-month follow-up 272
    Microsphere type Rapidly resorbable gelatin-based microspheres
    Follow-up period 12 months
    Key finding Significant, lasting pain relief + improved functional outcomes + improved quality of life at 12 months
    Safety Established; described as “real confidence” by Dr. Fleckenstein
    Procedure type Minimally invasive; image-guided catheter-based; outpatient
    Comparison No randomized placebo control — observational cohort design
    Global OA knee prevalence (WHO) 365 million adults
    U.S. OA prevalence ~32.5 million adults

    What the Study Found — and Why Scale Matters

    According to the Radiology abstract, 333 patients were included in the study, with 272 analyzed at the 12-month follow-up point. “This lets us speak about safety and efficacy with real confidence,” Dr. Fleckenstein told ScienceDaily. The study used validated outcome measures, including patient-reported pain scores and functional assessments, to document improvement.

    The clinical finding was clear: in patients with symptomatic knee osteoarthritis, GAE using rapidly resorbable microspheres provided long-lasting pain relief, improved functional outcomes, and enhanced quality of life across the 12-month observation period.

    According to Applied Radiology’s analysis, Dr. Fleckenstein framed the study’s significance specifically: “This study addresses osteoarthritis, which is a significant public health issue and the leading cause of chronic pain and disability worldwide. With millions of people affected by knee osteoarthritis, particularly in aging populations, finding effective, minimally invasive treatments is critical.”

    “GAE has the potential to reduce the need for more invasive surgeries, lower healthcare costs and significantly improve the quality of life for countless individuals suffering from knee osteoarthritis,” Dr. Fleckenstein added.

    An important technical caveat: this is a prospective observational cohort study, not a randomized controlled trial with a placebo or sham procedure comparison group. The absence of a randomized control arm means the study cannot fully exclude the placebo effect and selection bias as contributors to the observed outcomes. The evidence base for GAE is growing — including prior trials with permanent microspheres that also showed benefit — but the gold-standard randomized trial with a sham control remains an important next step in confirming GAE’s efficacy.

    Who Is an Appropriate Candidate for GAE?

    The procedure is designed for patients who have osteoarthritis-related knee pain that is no longer adequately controlled by conservative measures (physical therapy, NSAIDs, injections) but who are not candidates for or do not wish to pursue joint replacement surgery. This includes:

    • Patients who are too young or too active for joint replacement (where prosthetic lifespan becomes a concern)
    • Patients with medical comorbidities that increase surgical risk
    • Patients on blood thinners or immunosuppressants that complicate surgery
    • Patients who have declined joint replacement for personal reasons
    • Patients for whom prior injections have provided diminishing returns

    GAE is not appropriate for patients with advanced, end-stage osteoarthritis where the joint has lost virtually all cartilage, nor for patients with inflammatory arthritis (rheumatoid arthritis, psoriatic arthritis), local knee infection, significant peripheral arterial disease, or irreversible coagulopathy. Patient selection is performed by the interventional radiologist in consultation with an orthopedic specialist or rheumatologist.

    The procedure is typically performed in an outpatient or same-day surgery setting under conscious sedation. Recovery is significantly less demanding than joint replacement — most patients resume normal activities within days rather than weeks.

    The Road to Widespread Availability

    In the United States, GAE is currently performed primarily at academic medical centers and major hospital systems with active interventional radiology programs. It is not yet widely available at community hospitals. Insurance coverage is variable; Medicare and many private insurers have not universally adopted coverage policies for GAE, though this is an active and rapidly evolving area given the growing evidence base.

    The June 2026 Radiology study’s scale — 333 patients, 272 analyzed at 12 months — represents the largest body of evidence assembled for GAE using rapidly resorbable microspheres, and it is likely to support additional insurance coverage petitions and professional society guidance updates in the coming months.

    Frequently Asked Questions

    What is genicular artery embolization (GAE)?

    GAE is a minimally invasive procedure where an interventional radiologist uses a thin catheter to navigate to the blood vessels supplying an arthritic knee joint and injects small particles that block abnormal (pathological) vessels. By reducing the vascular contribution to joint inflammation, the procedure aims to provide sustained pain relief without surgery.

    How long does the pain relief from GAE last?

    In the June 2026 Radiology study, significant pain relief and improved functional outcomes were sustained at 12-month follow-up in the 272 patients analyzed. Longer-term follow-up data is still being collected.

    Is this better than cortisone injections?

    Cortisone (corticosteroid) injections typically provide relief lasting weeks to a few months. GAE has demonstrated 12-month sustained benefit in this study and prior research, suggesting it offers more durable relief than repeat injections for appropriately selected patients. However, direct head-to-head randomized comparison with injections has not yet been published.

    What does the procedure involve?

    An interventional radiologist makes a small puncture in the femoral artery, threads a catheter to the genicular arteries of the knee, identifies abnormal blood vessels using imaging, and injects tiny resorbable microspheres that block them. The procedure is performed under fluoroscopy guidance, typically with conscious sedation, in an outpatient setting.

    Is GAE covered by insurance?

    Coverage in the U.S. varies by insurer and is still evolving. Medicare and private insurers are reviewing coverage policies as the evidence base grows. Patients should check with their insurer and the interventional radiology team about coverage and prior authorization requirements.

    Source link

  • State-of-the-art Coronary Artery Disease Treatments

    State-of-the-art Coronary Artery Disease Treatments

    Coronary Artery Disease (CAD) remains a leading cause of death globally, but the treatments are rapidly changing. While traditional methods like lifestyle changes, medications, and surgeries have long been the cornerstone of care, these are now being enhanced by modern innovations. As highlighted by Nishi Patel, recent medical therapies target underlying biological processes, offering new hope to patients previously considered high-risk or untreatable.

    In parallel, imaging tools and minimally invasive techniques are transforming how physicians approach complex cases. Hybrid strategies and emerging technologies like robotics and gene therapy are also expanding the frontiers of what’s possible in cardiac care.

    Coronary Artery Disease and How It Is Traditionally Treated

    Coronary Artery Disease (CAD) develops when the arteries supplying blood to the heart become narrowed or blocked by plaque buildup. This reduces blood flow, which can lead to chest pain, shortness of breath, or even heart attacks. Common contributors include high cholesterol, smoking, high blood pressure, and diabetes.

    Traditional management of CAD focuses on relieving symptoms and preventing further heart damage. Lifestyle changes like improved diet and regular exercise are often combined with medications to control blood pressure and cholesterol. In more advanced cases, procedures such as stent placement or coronary artery bypass surgery are used to restore blood flow.

    Why Traditional Treatments May Not Be Enough

    While stents and bypass surgery have improved outcomes for many with coronary artery disease, they aren’t a universal solution. Some patients have arteries that are too affected, or their overall health may make surgery too risky. In these cases, traditional interventions may offer limited benefits or may even pose greater harm.

    Post-procedure recovery can also be challenging. Patients may deal with complications such as restenosis, where arteries narrow again after treatment. Others might not experience effective symptom relief, particularly if underlying risk factors remain uncontrolled. These limitations have led to a growing demand for more tailored and less invasive strategies. In addition, some individuals may require repeated interventions, increasing the burden on both the patient and the healthcare system.

    Advances in Medical Therapies and Risk Management

    Nishi Patel says that modern treatments emphasize aggressive medical therapy to address the root causes of CAD. Newer medications like PCSK9 inhibitors significantly reduce LDL cholesterol, while SGLT2 inhibitors are now recognized for their protective cardiovascular effects in patients with diabetes. These therapies are reshaping how clinicians manage risk beyond just symptom control.

    Managing lifestyle-related factors remains central. Digital health platforms now assist patients in tracking diet, exercise, and medication adherence. Participation in cardiac rehabilitation programs, both in-person and virtual, has been shown to improve outcomes by reinforcing long-term behavioral changes and reducing repeat cardiac events.

    Innovations in Minimally Invasive Procedures

    In recent years, interventional cardiology has grown with techniques that reduce the need for open-heart surgery. Imaging tools like intravascular ultrasound (IVUS) and optical coherence tomography (OCT) allow physicians to visualize plaque buildup within arteries in real time, leading to more precise placement of stents. These tools are especially useful in identifying vulnerable plaques that might not be visible on standard angiography.

    Chronic Total Occlusion (CTO) interventions, once considered high-risk and technically challenging, are now more successful due to advances in guidewire technology and operator skill. Patients with long-standing blockages who were previously told nothing could be done now have options that offer meaningful symptom relief. Some centers now specialize in these high-complexity cases, showing improved success rates and fewer complications.

    Drug-coated balloons and bioresorbable scaffolds are also gaining traction. These tools aim to restore blood flow without leaving behind permanent implants, reducing potential complications linked to traditional metal stents. The absence of a permanent structure may also lower the risk of late thrombosis, a concern with older implantable devices.

    Combining Techniques for Better Outcomes

    In complex coronary cases, a hybrid approach that blends surgical and catheter-based techniques can offer the best of both worlds. This strategy is often guided by a multidisciplinary heart team, where cardiologists, surgeons, and imaging specialists collaborate to tailor treatment. The combination of expertise allows for more nuanced decisions and improved procedural planning.

    Shared decision-making plays a crucial role in this process. Rather than a one-size-fits-all approach, patients are encouraged to participate in discussions about risks, benefits, and preferences. This model not only improves satisfaction but can also lead to better adherence and clinical success. As patient populations become more diverse, this individualized approach becomes increasingly important.

    Research and Emerging Technologies

    The future of coronary artery disease treatment is being shaped in labs and clinical trial centers around the world. Researchers are exploring gene therapies aimed at promoting vascular healing and reducing inflammation at the molecular level. Other analyses focus on regenerative techniques to repair damaged heart tissue.

    Nishi Patel explains that robotics and artificial intelligence are also making inroads into interventional cardiology. Robotic-assisted procedures offer greater precision and may reduce radiation exposure for patients and operators. AI-driven imaging analysis is beginning to support real-time decision-making in the cath lab. As these technologies progress, they could redefine how procedures are performed and who can benefit from them.

    Source link

  • ‘Don’t Push Too Hard,’ Warns Coach After Neck Artery Tear From Squats Trigger Strokes

    ‘Don’t Push Too Hard,’ Warns Coach After Neck Artery Tear From Squats Trigger Strokes

    Gym enthusiasts who pride themselves on pushing their limits for the perfect lift should take a moment to listen to the cautionary note of a gym instructor who suffered strokes after tearing her neck artery during squats.

    The 33-year-old fitness coach Bridgette Salatin from Ohio is still dealing with memory issues two years after the catastrophic stroke. Now easing back into her gym routine with lighter weights, she warns others: “Don’t push yourself too hard.”

    Salatin remembers the moment it happened; she was midway through a 70kg barbell squat when she suddenly felt dizzy, followed by a “really bad” headache. She had not eaten or slept enough the night before and had pushed her limits, holding her breath before lifting the weight.

    “When I woke up that day, I had a pain in my neck but I thought I’d probably just slept on it funny. I was squatting and I had a barbell on my back. I started to get a really bad headache,” Salatin said.

    The sharp pain shot from her shoulders to her right temple before she collapsed to the ground. Later, she learned the intense strain had torn an artery in her neck, triggering three mini-strokes.

    Doctors also diagnosed Salatin with occipital neuralgia, a painful neurological condition caused by injury or inflammation of the occipital nerves, which run through the scalp. The condition can result from pinched nerves, muscle tightness in the neck, or a head or neck injury.

    “They did a few scans on me and they said ‘you’ve had a stroke’ but how in the world does that happen at the age of 31? I felt an instant grief. I thought ‘I’ve failed myself’ and ‘am I ever going to be right again?’. I felt like I lost a sense of myself,” she recollected.

    Although months of bed rest and blood thinners helped her recover, Salatin said her life has never been the same, even two years later.

    “My short-term memory is gone and doing everyday things is hard for me. I used to teach a yoga class that was strictly on learning headstands but I can’t do that anymore,” she said.

    She now urges others to start with lighter weights and find a balance between pushing limits and avoiding injury.

    Source link

  • Healthy Young Man Nearly Dies From Stroke After Violent Sneeze Ruptures His Neck Artery

    Healthy Young Man Nearly Dies From Stroke After Violent Sneeze Ruptures His Neck Artery

    A fit and healthy young man in California is now facing a long and difficult recovery after suffering a major stroke, which nearly claimed his life. The stroke occurred after a seemingly harmless natural response—sneezing—caused a rupture in one of his neck arteries.

    Ian Applegate, a 35-year-old from Santa Cruz started experiencing alarming symptoms of stroke on Feb 9, after sneezing while sitting inside his car with his wife and their four-year-old son. It was Applegate’s first day back at work after being down with flu for a week.

    “I had just started the car and was getting ready to drive. I sneezed three times, then the third time it caused this blinding headache and made everything spin,” he recollected.

    Applegate suddenly felt an excruciating, blinding headache, intense dizziness that felt like the world was spinning, and severe shooting pain that radiated from his neck to the back of his head and left eye. Soon, he sensed pins and needles across his body and the entire left side including his face went numb.

    “The pain was excruciating. I was very disoriented and throwing up,” he said.

    Suspecting a stroke, he was quickly rushed to the Dominican Hospital in California. Doctors discovered that his violent sneeze had caused a vertebral artery dissection, which led to a blockage and interrupted blood flow to his brain, triggering the stroke.

    Vertebral artery dissection can occur without any clear cause but most likely occurs in people with certain health conditions, such as smoking, high blood pressure, or genetic disorders like Ehlers-Danlos syndrome (issues of connective tissues). It can also result from neck injuries such as from car accidents, heavy weightlifting, or even sneezing. Other risks include yoga, chiropractic adjustments, or any situation involving sudden or prolonged neck movements.

    Applegate was immediately put on blood-thinning medication to prevent further clotting and reduce the risk of additional complications. However, the severe stroke left him with significant damage to his left side, leaving him unable to swallow or walk without assistance, even a month after the incident.

    “It was a pretty hard sneeze but I’ve never experienced anything like this in my life. I never thought this was possible. I’m scared to sneeze now. My wife is eight months pregnant and I want to be there for the delivery.”

    “I can tell I’m going to struggle to take care of myself and the baby. I just want to be home in time for the baby’s birth. I’m trying to stay positive and continue my exercises until I get better,” he said.

    Source link